# Artiva Biotherapeutics, Inc. (ARTV): MoatMap facts

As of 27 Oct 2026. Research data, not investment advice.

As of 27 Oct 2026, MoatMap's StockRank for Artiva Biotherapeutics, Inc. (ARTV) is 18/100, ranked against 24,000+ stocks in 35 markets (Quality 29, Value 34, Momentum 35, each scored against its sector).

- StockRank: 18/100, a percentile across 24,000+ stocks in 35 markets (100 is best).
- Quality 29, Value 34, Momentum 35: each a 0-100 percentile within Healthcare.
- Position: #21,697 overall, #1,977 in Healthcare.
- Listing: United States, NGM; Healthcare / Biotechnology.
- Last close: 6.16 USD on 26 Oct 2026.
- Insider filings, last 180 days: directors bought USD 92.7M; directors sold USD 2.5M; 5%+ holders bought USD 16.5M.

Source: https://moatmap.ai/stock/ARTV
How the scores work: https://moatmap.ai/methodology
Does StockRank work? The public record: https://moatmap.ai/decile-tracker